首页图片新闻_NANOLATTIX - Cure cancer and maintain health

Nanolattix

Nanolattix

NEWS

新闻资讯

2025-07-09

Nanolattix Chairperson Dr. Zhican Qu Attends BIO 2025, Showcasing China's Biopharma Innovation

Nanolattix Chairperson Dr. Zhican Qu Attends BIO 2025, Showcasing China's Biopharma Innovation

2025-07-09

Clinical Trial Recruitment for T320, a Novel TF-Targeting Anti-Cancer Drug

Clinical Trial Recruitment for T320, a Novel TF-Targeting Anti-Cancer Drug

2025-07-09

Nanolattix’s T320-ADC Multi-Center Clinical Trials Initiated, Accelerating Development of Advanced Solid Tumor Therapies

Nanolattix’s T320-ADC Multi-Center Clinical Trials Initiated, Accelerating Development of Advanced Solid Tumor Therapies

Dr. Qu Zhican Takes Stage at 2025 China Pharmaceutical Innovation Summit and Delivers Keynote Speeches on RDC and ADC

Dr. Qu Zhican Takes Stage at 2025 China Pharmaceutical Innovation Summit and Delivers Keynote Speeches on RDC and ADC

01

2025/12

Dr. Qu Zhican Attends World ADC Conference, Unveils Nanolattix's Innovative "ADC + RDC Theranostic Integration" Strategy

Dr. Qu Zhican Attends World ADC Conference, Unveils Nanolattix's Innovative "ADC + RDC Theranostic Integration" Strategy

11

2025/11

Nanolattix

Nanolattix

WeChat Public Number

Copyright©2024 Shanxi Nanolattix Biotechnology Co., Ltd.

Powered by 300.cn | SEO

Business License